GLOBUS MEDICAL INC
GMEDGlobus Medical, Inc. is a publicly traded orthopedic medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders.
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
How GMED's past catalysts played out
No drugs found in this phase.
Frequently asked questions
When is GLOBUS MEDICAL INC's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for GLOBUS MEDICAL INC (GMED) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track GMED biotech catalysts?→
Add GMED to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow GLOBUS MEDICAL INC's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.